Document ID: chunk:federal_register_of_legislation:F2023L00941:clause:1_1:p4
Version: federal_register_of_legislation:F2023L00941
Segment Type: clause
Provision Reference: sch 1 cl 1 (pt 4/5)
Character Range: 31531–36075

concentration of >1 ppm;
(f)           methyl bromide at an inhaled concentration of >0.02 ppm;
(g)          methyl n-butyl ketone (MNBK) at an inhaled concentration of >0.6 ppm; or
(h)          n-hexane at an inhaled concentration of >0.6 ppm.
                               specified list of chemicals (short term exposure) means:
(a)          acrylamide monomer at an oral dose rate of >0.01 mg/kg/day;
(b)          1-bromopropane at an inhaled concentration of >1 ppm or an oral dose rate of >0.001 mg/kg/day;
(c)          carbon disulphide at an inhaled concentration of >0.3 ppm;
(d)          dimethylaminopropionitrile;
(e)          ethylene oxide at an inhaled concentration of >5 ppm;
(f)           methyl bromide at an inhaled concentration of >0.02 ppm;
(g)          methyl n-butyl ketone (MNBK) at an inhaled concentration of >0.6 ppm; or
(h)          n-hexane at an inhaled concentration of >0.6 ppm.
                               specified list of drugs means
(a)          amiodarone;
(b)          arsenic trioxide;
(c)          atezolizumab;
(d)          bortezomib;
(e)          brentuximab vedotin;
(f)           carfilzomib;
(g)          cycloserine;
(h)          dichloroacetate;
(i)            disulfiram;
(j)            fludarabine;
(k)          fluoroquinolone antibiotics, excluding topical formulations;
(l)            ipilimumab;
(m)        isoniazid;
(n)          itraconazole;
(o)          linezolid;
(p)          methotrexate;
(q)          metronidazole;
(r)           misonidazole;
(s)           nitrofurantoin;
(t)            pemetrexed;
(u)          platinum compounds;
(v)          pomalidomide;
(w)        statins;
(x)          taxanes;
(y)          thalidomide;
(z)          trastuzumab;
(aa)       trastuzumab emtansine;
(bb)      vigabatrin;
(cc)       vinca alkaloids; or
(dd)      zalcitabine (ddC).
                               specified list of drugs that cannot be ceased or substituted means:
(a)          5-fluorouracil;
(b)          acitretin;
(c)          altretamine;
(d)          auranofin;
(e)          aurothioglucose;
(f)           benznidazole;
(g)          brigatinib;
(h)          chloramphenicol;
(i)            chloroquine;
(j)            chlorprothixene;
(k)          colchicine;
(l)            crizotinib;
(m)        cytosine arabinoside;
(n)          dapsone;
(o)          daptomycin;
(p)          didanosine (ddI);
(q)          encorafenib;
(r)           entrectinib;
(s)           eribulin mesylate;
(t)            etanercept;
(u)          ethambutol;
(v)          etoposide;
(w)        etravirine;
(x)          gemcitabine;
(y)          glutethimide;
(z)          griseofulvin;
(aa)       hexamethylmelamine;
(bb)      hydralazine;
(cc)       hydroxychloroquine;
(dd)      infliximab;
(ee)       interferon alpha;
(ff)        ixabepilone;
(gg)      leflunomide;
(hh)      lenolidamide;
(ii)         levodopa;
(jj)         lithium;
(kk)      lorlatinib;
(ll)         mefloquine;
(mm) nitrous oxide with prolonged use over 24 hours;
(nn)      nifurtimox;
(oo)      peginterferon alpha-2a;
(pp)      perhexiline maleate;
(qq)      phenytoin;
(rr)        podophyllin;
(ss)        ponatinib;
(tt)         procarbazine;
(uu)      sorafenib;
(vv)      stavudine (d4T);
(ww)  sulphasalazine;
(xx)      suramin;
(yy)      telbivudine;
(zz)       teniposide;
(aaa)   teriflunomide;
(bbb)  tioguanine; or
(ccc)   voriconazole.
                               specified list of endocrine diseases means:
(a)          acromegaly;
(b)          diabetes mellitus;
(c)          hyperthyroidism, including goitre and Graves disease that has resulted in hyperthyroidism;
(d)          hypothyroidism, including Hashimoto thyroiditis that has resulted in hypothyroidism; or
(e)          thyrotoxicosis.
Note: acromegaly is also defined in the Schedule 1 – Dictionary.
                               specified list of forms of systemic vasculitis means:
(a)          Behçet disease;
(b)          eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome);
(c)          giant cell (temporal) arteritis;
(d)          granulomatosis with polyangiitis (Wegener granulomatosis);
(e)          Henoch-Schonlein purpura (IgA vasculitis);
(f)           microscopic polyangiitis;
(g)          mixed cryoglobulinaemia; or
(h)          polyarteritis nodosa.
                               specified list of haematological or lymphoproliferative disorders means:
(a)          acute lymphoblastic leukaemia/lymphoblastic lymphoma;
(b)          acute myeloid leukaemia;
(c)          mature B-cell lymphoid